Back to search
Prodromal Alzheimer's Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prodromal Alzheimer's Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prodromal Alzheimer's Disease trials you may qualify forThe goal of this clinical trial is to investigate whether very small doses of a drug called levetiracetam (LEV) may reduce abnormal brain signaling in individua…
In this research study we want to learn more about the effects of non-invasive brain stimulation on motivation, memory, and brain-network function in cognitivel…
Development of novel disease-modifying therapies for Alzheimer's disease (AD) remains of paramount importance. This study will be a Phase II randomized clinical…
Neurodegenerative diseases are a major health concern due to their growing societal implications and economic costs. The identification of early markers of path…
The purpose of this study is to assess the safety, tolerability, immunogenicity and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's…
This study is a multicenter, randomized, double-blind, parallel-group, prospective confirmatory clinical trial designed to evaluate whether the Neuclare medical…
Alzheimer's disease (AD) is the most common form of dementia. In the brains of people with AD, certain small substances stick together. This leads to changes in…
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiority of lecane…